FindTrial
Sign In

Clinical features and identification of high-risk groups with comorbid anxiety and depression in patients with neurological diseases: A single-center cross-sectional study.

Clinical features and identification of high-risk groups with comorbid anxiety and depression in patients with neurological diseases: A single-center cross-sectional study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109986
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological diseases with comorbid anxiety and depression symptoms

Interventions

Observational group:None

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed with a neurological disorder (e.g., stroke, epilepsy, Parkinson’s disease, multiple sclerosis, etc.); 2. Complete documentation of standardized anxiety/depression assessment scales (HAMD, HAMA) in the medical record; 3. Age >= 18 years.

Exclusion criteria

Exclusion criteria: 1. Incomplete data (including missing key demographic variables or scale scores); 2. Co-occurrence with other severe psychiatric disorders (e.g., schizophrenia, bipolar disorder); 3. Severe cognitive impairment or inability to cooperate with assessment.

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Rating Scale (HAMA) score;Hamilton Depression Rating Scale (HAMD) score;—

Countries

China

Contacts

Public ContactGuo Yi

Shenzhen People's Hospital

xuanyi_guo@163.com+86 139 0297 8692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026